Postpartum Depression

This study is evaluating RE104, an investigational psychedelic drug, as a potential treatment for PPD

• Have you had a baby in the last 15 months?
• Are you experiencing symptoms of depression, such as sadness, anxiety, or feelings of being overwhelmed?

If so, you may have postpartum depression.

With the RECONNECT Study, research is being done on a possible treatment for Postpartum Depression (PPD).

By participating in the RECONNECT Study, you could contribute to the development of a potential new treatment for postpartum depression that may benefit thousands of women who are experiencing similar symptoms. 

All trial-related assessments and medical care will be provided at no cost (no insurance required). Eligible participants will receive compensation for time and travel to attend trial visits.

Find out if participating in our medical research study of a new single-dose investigational drug for postpartum depression may be an option for you.

Minimum Requirements to Participate

You may be eligible to join this study if:

• You are a female 18 to 45 years of age
• You had your baby sometime in the last 15 months
• You are experiencing signs of depression
• You have a caretaker you can look after your baby during the dosing session and for 24 hours after dosing